Results 111 to 120 of about 17,019 (205)

Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan

open access: yesmAbs
Recent developments in targeted protein degradation have provided great opportunities to eliminating extracellular protein targets using potential therapies with unique mechanisms of action and pharmacology.
Kaori Mukai   +11 more
doaj   +1 more source

Evidence of mature adipocyte proliferation regulated by proliferin [PDF]

open access: yes, 2010
Despite much research, whether mature adipocytes proliferate remains controversial. Here, we examined 5-bromo-2′-deoxyuridine (BrdU)-labelling of mature adipocytes.
Aki Minami   +16 more
core   +1 more source

Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease

open access: yesFrontiers in Neurology
Enzyme replacement therapy (ERT) is the only approved disease-modifying treatment modality for Pompe disease, a rare, inherited metabolic disorder caused by a deficiency in the acid α-glucosidase (GAA) enzyme that catabolizes lysosomal glycogen.
Barry J. Byrne   +17 more
doaj   +1 more source

IFT20 regulates TFEB-dependent lytic granule biogenesis in cytotoxic T lymphocytes by orchestrating the MPR-dependent transport of granzyme B

open access: yesCell Death and Disease
Cytotoxic T lymphocytes (CTL) exploit specialized secretory lysosomes, the lytic granules (LG) to kill target cells. The LGs carry a battery of apoptosis-inducing molecules enriched in granzymes (GZM), perforin and FasL, which are released at the immune ...
Francesca Finetti   +10 more
doaj   +1 more source

Role for Dynamin in Late Endosome Dynamics and Trafficking of the Cation-independent Mannose 6-Phosphate Receptor

open access: green, 2000
Paolo Nicoziani   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy